Relative dose intensity over the first four weeks of lenvatinib therapy is a factor of favorable response and overall survival in patients with unresectable hepatocellular carcinoma

Relative dose intensity over the first four weeks of lenvatinib therapy is a factor of favorable response and overall survival in patients with unresectable hepatocellular carcinoma

Lenvatinib is an approved first-line therapy for unresectable hepatocellular carcinoma (HCC), but the effect of dose modification on its efficacy is unclear. We analyzed the relationship between the relative dose intensity during the initial 4 weeks of therapy [4W-relative dose intensity (RDI)] and...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Sakura Kirino, Kaoru Tsuchiya, Masayuki Kurosaki, Shun Kaneko, Kento Inada, Koji Yamashita, Leona Osawa, Yuka Hayakawa, Shuhei Sekiguchi, Mao Okada, Wan Wang, Mayu Higuchi, Kenta Takaura, Chiaki Maeyashiki, Nobuharu Tamaki, Yutaka Yasui, Hiroyuki Nakanishi, Jun Itakura, Yuka Takahashi, Yasuhiro Asahina, Namiki Izumi
Natura: Artigo
Lingua:inglese
Pubblicazione: 2020
Accesso online:https://doi.org/10.1371/journal.pone.0231828
https://storage.googleapis.com/plos-corpus-prod/10.1371/journal.pone.0231828/1/pone.0231828.pdf?X-Goog-Algorithm=GOOG4-RSA-SHA256&X-Goog-Credential=wombat-sa%40plos-prod.iam.gserviceaccount.com%2F20210221%2Fauto%2Fstorage%2Fgoog4_request&X-Goog-Date=20210221T143530Z&X-Goog-Expires=3600&X-Goog-SignedHeaders=host&X-Goog-Signature=276898d3266a66ba8e32c96a7c7db9e693b2b7c921c7e9d3ea2e664c15059bde086c9d8d9042043b4c3112cffc87be3aedbc72047889fa1f37ee79e628400b2bd0704755f6870f367b118fd9bfa1f76cb638b473087e3a1cb81a44bfd6572d2514c6de77ac7e007bf85ad962b1bf50908807f0d706eef75161012e54892c4bbe5a3943900ef63b71e3ba12e1ce756734ba4097075d510ac9a21c7716d654d812ac08b737072132459b216a33fe7e8cf163493e1dd265d018d9090e8f9e0167e011622b419e5babc0ac82ce3b0f843e897ac382ce9e38f35fc98186823c6be54a13ad8833e2618d534ae9df394f06b6d946ceae37b2718376a46ffc294c9bf8f1
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!

Accesso online

https://doi.org/10.1371/journal.pone.0231828
https://storage.googleapis.com/plos-corpus-prod/10.1371/journal.pone.0231828/1/pone.0231828.pdf?X-Goog-Algorithm=GOOG4-RSA-SHA256&X-Goog-Credential=wombat-sa%40plos-prod.iam.gserviceaccount.com%2F20210221%2Fauto%2Fstorage%2Fgoog4_request&X-Goog-Date=20210221T143530Z&X-Goog-Expires=3600&X-Goog-SignedHeaders=host&X-Goog-Signature=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

Documenti analoghi